Februari 2012
27
4.
Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-
chain fatty acid oxidation defects before and after newborn screening.
J Inherit Metab Dis.
2010;33:527-532.
5.
Spiekerkoetter U, Lindner M, Santer R, Grotzke M, Baumgartner MR, Boehles H, et al.
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects:
results from a workshop.
J Inherit Metab Dis.
2009;32:488-497.
6.
Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation:
experience and recommendations from an expert meeting.
J Inherit Metab Dis.
2010;33:521-
526.
7.
Hagenfeldt L, Venizelos N, von DU. Clinical and biochemical presentation of long-chain 3-
hydroxyacyl-CoA dehydrogenase deficiency.
J Inherit Metab Dis.
1995;18:245-248.
8.
Sykut-Cegielska J, Gradowska W, Piekutowska-Abramczuk D, Andresen BS, Olsen RK,
Oltarzewski M, et al. Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-
CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot
newborn screening.
J Inherit Metab Dis.
2011;34:185-195.
9.
Sperk A, Mueller M, Spiekerkoetter U. Outcome in six patients with mitochondrial
trifunctional protein disorders identified by newborn screening.
Mol Genet Metab.
2010;101:205-207.
10.
den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA.
Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with
cardiac and neurologic involvement.
J Pediatr.
2003;142:684-689.
11.
Gillingham M, Van CS, Ney D, Wolff J, Harding C. Dietary management of long-chain 3-
hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey.
J Inherit
Metab Dis.
1999;22:123-131.
12.
den Boer ME, Wanders RJ, Morris AA, Ijlst L, Heymans HS, Wijburg FA. Long-chain 3-
hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50
patients.
Pediatrics.
2002;109:99-104.
13.
Acute Ilness Protocol - Fatty Acid Oxidation Disorders - LCHADD. In: The New England
Consortium of Metabolic Programs, http:, newenglandconsortium.org/for-
professionals/acute-illness-protocols/, editors. 2011.
14.
Steinmann D, Knab J, Priebe HJ. Perioperative management of a child with long-chain 3-
hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.
Paediatr Anaesth.
2010;20:371-373.
15.
Harding CO, Gillingham MB, van Calcar SC, Wolff JA, Verhoeve JN, Mills MD.
Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA
dehydrogenase deficiency.
J Inherit Metab Dis.
1999;22:276-280.
16.
Tein I, Donner EJ, Hale DE, Murphy EG. Clinical and neurophysiologic response of myopathy
and neuropathy in long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency to oral
prednisone.
Pediatr Neurol.
1995;12:68-76.